Correlation Between Fate Therapeutics and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Madrigal Pharmaceuticals.
Diversification Opportunities for Fate Therapeutics and Madrigal Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fate and Madrigal is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Madrigal Pharmaceuticals. In addition to that, Fate Therapeutics is 1.27 times more volatile than Madrigal Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.18 per unit of volatility. If you would invest 31,092 in Madrigal Pharmaceuticals on November 28, 2024 and sell it today you would earn a total of 6,034 from holding Madrigal Pharmaceuticals or generate 19.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fate Therapeutics vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Fate Therapeutics |
| Madrigal Pharmaceuticals |
Fate Therapeutics and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and Madrigal Pharmaceuticals
The main advantage of trading using opposite Fate Therapeutics and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |